Skip to content

Clinical trials

Purpura, Thrombocytopenic, Idiopathic trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Country / region: Russia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20071
20081
20121
20131
20142
20181
20191
20206
20214
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
argenx4
Novartis Pharmaceuticals3
UCB Biopharma SRL3
AO GENERIUM2
Amgen1
Bristol-Myers Squibb1
CSL Behring1
Kezar Life Sciences, Inc.1
Principia Biopharma, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic23
Thrombocytopenia8
Purpura6
Hemorrhage3
Ecchymosis2
Anemia1
Anemia, Hemolytic, Autoimmune1
Blood Platelet Disorders1
Hematologic Diseases1
Hemolysis1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.